EQUITREX – 350mg/ml

Description

Boldenone Undecylenate 350mg/ml 1 VIAL containing 10 ml

For multidose use

FOR VETERINARY USE ONLY

Therapeutic Class: Anabolic Agent

Composition:

Each 1 ml of EQU ITREX 350 contains:

• 350 mg Boldenone Undecylenate
• Ethlyl Oleate q.s.

Indication & Dosage:

FOR INTRAMUSCULAR USE IN HORSES ONLY

Certain pathophysiological or catabolic processes in animals.

As anabolic after debilitating illness

The dosage for horses is 0.28 to 1.10 mg/kg (0.13-0.5 mg/lb) of body weight intramuscularly. Treatment may be repeated every 2 to 3 weeks.

The condition should be assessed by a veterinarian to determine the duration of treatment; however, most horses will respond with one or two treatments.

Contraindications:

In the absence of data on the effect of boldenone undecylenate on immature colts and fillies, stallions, pregnant mares or brood mares during the breeding season, this drug should not be used in these animals.

Special Precautions:

For horses only. This drug is not to be administered to horses that are to be slaughtered for use in food. Keep out of reach of children.

Adverse Drug Reactions:

Treatment with EQUITREX injectable (boldenone undecylenate injection) may result in androgenic effects (masculinization, behavioural effects) being expressed in some animals. If these effects occur, they may persist for up to 6 to 8 weeks. No additional injections of boldenone undecylenate should be administered.

Drug Interactions:

May increase effects of oral anticoagulants, insulin, oral antidiabetic agents, adrenal steroid, adrenocorticotropic hormone (ACTH).

Pregnancy Category:

Category X: Studies in animals beings have demonstrated foetal abnormalities or there is evidence of foetal risk.

Storage:

Store at room temperature, between 59 and 86 degrees F (15 and 30 degrees C), in a tightly-closed container. Store away from heat, moisture, and light.

Do not store in the bathroom. Keep out of the reach of children and away from pets.